MARKET

PDSB

PDSB

Pds Biotechnology Corporation
NASDAQ
0.7698
-0.0333
-4.15%
After Hours: 0.7500 -0.0198 -2.57% 19:59 12/31 EST
OPEN
0.8094
PREV CLOSE
0.8031
HIGH
0.8094
LOW
0.7620
VOLUME
669.52K
TURNOVER
--
52 WEEK HIGH
2.200
52 WEEK LOW
0.7030
MARKET CAP
40.32M
P/E (TTM)
-0.9396
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PDSB last week (1222-1226)?
Weekly Report · 12/29/2025 09:06
Weekly Report: what happened at PDSB last week (1215-1219)?
Weekly Report · 12/22/2025 09:06
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 12/18/2025 12:05
Weekly Report: what happened at PDSB last week (1208-1212)?
Weekly Report · 12/15/2025 09:07
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 12/09/2025 21:07
PDS Biotechnology Secures New Patent for PDS0101
TipRanks · 12/09/2025 13:28
PDS announces new composition of matter patent for PDS0101 in Japan
TipRanks · 12/09/2025 13:10
PDS BIOTECHNOLOGY CORP - NEW PATENT EXPANDS JAPAN PATENTS AND IP ESTATE
Reuters · 12/09/2025 13:08
More
About PDSB
PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is developing a pipeline of targeted cancer immunotherapies based on its Versamune T cell-activator and Versamune in combination with its interleukin 12 (IL-12) fused antibody drug conjugate (ADC), PDS01ADC, a tumor targeting immunocytokine. PDS0101 is its lead Versamune based immunotherapy. PDS0101 combines Versamune with a mixture of short proteins (peptides) derived from the cancer-causing HPV16 viral protein. Versamune is a proprietary lipid nanoparticle and T cell activating platform. PDS0301 is an investigational tumor-targeting antibody conjugate of Interleukin 12 (IL-12) that enhances the proliferation, potency, infiltration, and longevity of T cells in the tumor microenvironment. Its Versamune immunotherapies and Versamune in combination with PDS01ADC, are utilized for treatments in oncology, and Infectimune is utilized for preventive vaccines against infectious agents.

Webull offers PDS Biotechnology Corp stock information, including NASDAQ: PDSB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PDSB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PDSB stock methods without spending real money on the virtual paper trading platform.